Glucose Monitoring in Tissue Transfers

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00962130

Enrollment

Registered

2009-08-19

Start date

2009-08-31

Completion date

2011-06-30

Last updated

2018-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reconstructive Tissue Surgery

Keywords

tissue perfusion, reconstructive surgery, continuous glucose monitoring

Brief summary

The purpose of this study is to determine if 1) a continuous glucose monitoring system can measure glucose levels in transferred tissue during reconstructive surgery, and 2) if glucose measurements from a continuous glucose monitoring system correlate with tissue blood perfusion.

Interventions

DEVICEContinuous glucose monitoring system

one or two monitors will be placed in the tissue to be transferred

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* presence of a soft tissue deformity where reconstruction with a pedicled or free tissue transfer is indicated * age 18 and over * ability to follow-up post-operatively

Exclusion criteria

* age less than 18 * prisoner status * inability to participate in a standard post-operative follow-up visit

Design outcomes

Primary

Measure	Time frame
Perfusion and tissue transfer outcome during reconstructive surgery predicted by continuous glucose monitoring of tissue	Up to three days post-op

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026